Rare Disease Trial, Recruiting NCT03287193 Sponsor: Centre Hospitalier Universitaire Dijon Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT03287193
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children or adults who are suspected of having a rare disease (or a rare form of a common disease) that is thought to be genetic, but where the genetic cause or how the disease works is not yet fully understood
  • Unborn babies (foetuses) who have developmental abnormalities where the genetic cause or how the condition works is not yet fully understood
  • Family members who appear to be healthy, or people participating as comparison (control) participants
  • The patient, or their legal guardian if the patient cannot consent for themselves, must agree to take part
  • The patient or their guardian must have a suitable level of understanding to participate

Who may not be able to join:

  • People who do not have national health insurance coverage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire Dijon
Registry
ClinicalTrials.gov
Start date
13 March 2017
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of new genes or genetic abnormalities identified.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov